» Articles » PMID: 31615600

Prevalence, Risk Factors and Genetic Characterisation of Extended-spectrum Beta-lactamase and Carbapenemase-producing Enterobacteriaceae (ESBL-E and CPE): a Community-based Cross-sectional Study, the Netherlands, 2014 to 2016

Overview
Journal Euro Surveill
Date 2019 Oct 17
PMID 31615600
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

BackgroundThe epidemiology of carriage of extended-spectrum beta-lactamase-producing (ESBL-E) and carbapenemase-producing Enterobacteriaceae (CPE) in the general population is unknown.AimIn this observational study, the prevalence and risk factors for intestinal ESBL-E and CPE carriage in the Dutch general population were determined. ESBL-E were characterised.MethodsFrom 2014 to 2016, ca 2,000 residents were invited monthly to complete a questionnaire and provide a faecal sample, which was tested for ESBL-E. The first 1,758 samples were also tested for CPE. Risk factors for ESBL-E carriage were identified by multivariable logistic regression analysis. ESBL-E isolates underwent whole genome sequencing.ResultsOf 47,957 individuals invited, 4,177 (8.7%) completed the questionnaire and provided a faecal sample. ESBL-E were detected in 186 (4.5%) individuals, resulting in an adjusted prevalence of 5.0% (95% confidence interval (CI):3.4-6.6%). Risk factors were: born outside the Netherlands (odds ratio (OR): 1.99; 95% CI: 1.16-4.54), eating in restaurants > 20 times/year (OR: 1.70; 95% CI: 1.04-2.76), antibiotic use < 6 months ago (OR: 2.05; 95% CI: 1.05-4.03), swimming in sea/ocean < 12 months ago (OR: 1.63; 95% CI: 1.11-2.39), travelling to Africa (OR: 3.03; 95% CI: 1.23-7.46) or Asia (OR: 2.00; 95% CI: 1.02-3.90) < 12 months ago, and not changing kitchen towels daily (OR: 2.19; 95% CI: 1.24-3.87). The last had the largest population attributable risk (PAR) (47.5%). Eighty-four of 189 (44.4%) ESBL-E isolates carried . isolates belonged to 70 different sequence types (ST)s, of which ST131 (42/178 isolates; 23.6%) was most prevalent. Associations were observed between IncFIA plasmids and ST131 and , and between IncI1 and ST88 and . No CPE were detected.ConclusionsThe prevalence of ESBL-E carriage in the Netherlands' community-dwelling population is 5.0%. Identified risk factors were mostly travelling (particularly to Asia and Africa) and kitchen hygiene. CPE were not detected.

Citing Articles

Companions in antimicrobial resistance: examining transmission of common antimicrobial-resistant organisms between people and their dogs, cats, and horses.

Caddey B, Fisher S, Barkema H, Nobrega D Clin Microbiol Rev. 2025; 38(1):e0014622.

PMID: 39853095 PMC: 11905369. DOI: 10.1128/cmr.00146-22.


Genomic epidemiology of extended-spectrum beta-lactamase-producing from humans and a river in Aotearoa New Zealand.

Gray H, Biggs P, Midwinter A, Rogers L, Fayaz A, Akhter R Microb Genom. 2025; 11(1.

PMID: 39791259 PMC: 11718517. DOI: 10.1099/mgen.0.001341.


One decade of point-prevalence surveys for carriage of extended-spectrum beta-lactamase-producing enterobacterales: whole genome sequencing based prevalence and genetic characterization in a large Dutch teaching hospital from 2013 to 2022.

Houkes K, Weterings V, van den Bijllaardt W, Tinga M, Mulder P, Kluytmans J Antimicrob Resist Infect Control. 2024; 13(1):102.

PMID: 39267161 PMC: 11396308. DOI: 10.1186/s13756-024-01460-y.


Efficacy of an inulin-based treatment on intestinal colonization by multidrug-resistant E. coli: insight into the mechanism of action.

Ishnaiwer M, Le Bastard Q, Naour M, Zeman M, Dailly E, Montassier E Gut Microbes. 2024; 16(1):2347021.

PMID: 38685762 PMC: 11062366. DOI: 10.1080/19490976.2024.2347021.


Cross-border differences in the prevalence and risk factors for carriage of antimicrobial resistance in children attending daycare centers: a point prevalence study in the Netherlands and Belgium.

Dequeker S, van Hensbergen M, den Heijer C, Dhaeze W, Raven S, Ewalts-Hakkoer H BMC Infect Dis. 2024; 24(1):131.

PMID: 38267878 PMC: 10809597. DOI: 10.1186/s12879-024-08996-9.


References
1.
Ny S, Lofmark S, Borjesson S, Englund S, Ringman M, Bergstrom J . Community carriage of ESBL-producing Escherichia coli is associated with strains of low pathogenicity: a Swedish nationwide study. J Antimicrob Chemother. 2016; 72(2):582-588. DOI: 10.1093/jac/dkw419. View

2.
Paltansing S, Vlot J, Kraakman M, Mesman R, Bruijning M, Bernards A . Extended-spectrum β-lactamase-producing enterobacteriaceae among travelers from the Netherlands. Emerg Infect Dis. 2013; 19(8):1206-13. PMC: 3739527. DOI: 10.3201/eid.1908.130257. View

3.
Van Den Bunt G, Liakopoulos A, Mevius D, Geurts Y, Fluit A, Bonten M . ESBL/AmpC-producing Enterobacteriaceae in households with children of preschool age: prevalence, risk factors and co-carriage. J Antimicrob Chemother. 2016; 72(2):589-595. DOI: 10.1093/jac/dkw443. View

4.
Carattoli A, Bertini A, Villa L, Falbo V, Hopkins K, Threlfall E . Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005; 63(3):219-28. DOI: 10.1016/j.mimet.2005.03.018. View

5.
Huizinga P, van den Bergh M, van Rijen M, Willemsen I, van t Veer N, Kluytmans J . Proton Pump Inhibitor Use Is Associated With Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Rectal Carriage at Hospital Admission: A Cross-Sectional Study. Clin Infect Dis. 2016; 64(3):361-363. DOI: 10.1093/cid/ciw743. View